Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-31 Sale | 2023-06-02 5:35 pm | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 25,400 | $2.5178 | $63,953 | 5,224,600 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-08-09 5:11 pm | N/A N/A | Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner | 0 | $0 | 8,426,955 (Indirect) | View |
| 2024-06-07 Option Award | 2024-06-11 4:20 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 15,900 | $0 | 21,900 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 23,500 | $0 | 23,500 (Direct) | View |
Ownership | 2023-06-02 5:33 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 0 | $0 | 5,250,000 (Indirect) | View |
| 2022-06-17 Option Award | 2022-06-21 4:46 pm | N/A 2032-06-16 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 5:00 pm | N/A 2031-06-21 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-22 4:20 pm | N/A 2030-06-18 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 12,500 | $0 | 12,500 (Direct) | View |